Understanding the Types of Diabetes: Type 1, Type 2 & Gestational
Diabetes mellitus is a group of metabolic disorders characterized by chronic hyperglycemia. The three main types have distinct etiologies, pathophysiology, and management.
1. Type 1 Diabetes (T1D)
- Cause: Autoimmune destruction of pancreatic β-cells → absolute insulin deficiency.
- Onset: Typically childhood/adolescence, but can occur at any age (LADA in adults).
- Prevalence: ~5–10% of diabetes cases.
- Management: Lifelong exogenous insulin (multiple daily injections or pump), glucose monitoring (CGM preferred), carbohydrate counting, education. No insulin = diabetic ketoacidosis (DKA) → death.
- Risk Factors: Genetics (HLA-DR3/DR4), family history, environmental triggers (viruses, early diet?). Not lifestyle-related.
2. Type 2 Diabetes (T2D)
- Cause: Insulin resistance (muscle, liver, adipose) + progressive β-cell dysfunction → relative insulin deficiency.
- Onset: Typically >40 years, but rising in youth due to obesity.
- Prevalence: ~90–95% of cases.
- Management: Lifestyle (diet, exercise, weight loss) → metformin first-line → add GLP-1 RA, SGLT2i, DPP-4i, TZD, SU, basal insulin per guidelines (ADA/EASD). Individualized HbA1c target (usually <7%).
- Risk Factors: Obesity (esp. visceral), inactivity, family history, race/ethnicity, age, GDM history, PCOS, metabolic syndrome.
3. Gestational Diabetes Mellitus (GDM)
- Cause: Placental hormones (hPL, cortisol, progesterone) induce insulin resistance in late pregnancy; β-cells cannot compensate sufficiently.
- Screening: 24–28 weeks (1-step 75g OGTT or 2-step 50g screen → 100g OGTT).
- Management: Medical nutrition therapy, glucose monitoring, exercise → insulin if targets not met (oral agents generally avoided in US).
- Postpartum: Usually resolves, but 50% develop T2D within 10 years. Lifelong screening (1–3 years). Offspring at higher metabolic risk.
Other Types (Brief)
- Monogenic (MODY, Neonatal): Single gene mutations; often misdiagnosed as T1/T2.
- Pancreatogenic (Type 3c): Pancreatic disease (chronic pancreatitis, cystic fibrosis, resection).
- Drug/Chemical-Induced: Glucocorticoids, antipsychotics, protease inhibitors, etc.
Accurate classification guides therapy, monitoring, and counseling. Autoantibody testing (GAD65, IA-2, ZnT8, IAA) and C-peptide help differentiate T1D from T2D/LADA when unclear.
Diabetes - Related Articles
- Clinical Trials for EGFR-Positive NSCLC: What Patients Need to Know
- Pre-Diabetes Diet: Prevention & Management | [Your Brand/Website]
- A History of Insulin Pumps: From Backpacks to Modern Technology
- Herbal Remedies for Diabetes Management: Evidence-Based Approaches
- Understanding Weight Loss and Diabetes: Causes & Types
- Heart-Healthy Diabetic Diet: Manage Blood Sugar & Lower Risk
- Metabolic Acidosis in Diabetes: Symptoms, Causes & Diagnosis
